Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Myos Rens Tech (MYOS)

Myos Rens Tech (MYOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 12,314
  • Shares Outstanding, K 12,192
  • Annual Sales, $ 1,030 K
  • Annual Income, $ -4,260 K
  • 60-Month Beta 1.08
  • Price/Sales 13.35
  • Price/Cash Flow N/A
  • Price/Book 6.09
Trade MYOS with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.34
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date 11/05/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.9800 +3.06%
on 10/27/20
1.3310 -24.12%
on 10/19/20
-0.2900 (-22.31%)
since 10/16/20
3-Month
0.9800 +3.06%
on 10/27/20
1.5600 -35.26%
on 08/20/20
-0.5200 (-33.99%)
since 08/17/20
52-Week
0.7412 +36.27%
on 03/18/20
3.8500 -73.77%
on 07/01/20
-0.4700 (-31.76%)
since 11/15/19

Most Recent Stories

More News
MedAvail and MYOS RENS Technology Announce Closing of Business Combination

MedAvail, Inc. (“MedAvail”), a leading technology-enabled pharmacy organization that embeds pharmacy services directly into clinics and other points of care through its proprietary technology, announced...

MYOS : 12.1200 (-10.62%)
ALERT: Halper Sadeh LLP is Investigating Whether the Following Mergers are Fair to Shareholders; Investors are Encouraged to Contact the Firm - MYOS, NGHC, BFYT

NEW YORK, NY / ACCESSWIRE / July 18, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating whether the following mergers are fair to shareholders. Halper Sadeh LLP may seek increased...

MYOS : 12.1200 (-10.62%)
NGHC : 34.18 (+0.09%)
BFYT : 31.00 (+0.10%)
MYOS RENS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of MYOS RENS Technology, Inc. - MYOS

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of MYOS RENS Technology, Inc. (NasdaqCM: MYOS)...

MYOS : 12.1200 (-10.62%)
ALERT: Halper Sadeh LLP Continues to Investigate Whether the Following Mergers are Fair to Shareholders; Investors are Encouraged to Contact the Firm - DCOM, REXN, MYOS

NEW YORK, NY / ACCESSWIRE / July 8, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate whether the following mergers are fair to shareholders. Halper Sadeh LLP may seek...

DCOM : 18.01 (-1.85%)
REXN : 7.2400 (-3.21%)
MYOS : 12.1200 (-10.62%)
SHAREHOLDER INVESTIGATION ALERT: Halper Sadeh LLP Is Investigating Whether the Following Mergers are Fair to Shareholders; Investors are Encouraged to Contact the Firm - NVTA, MYOS, DCOM

NEW YORK, NY / ACCESSWIRE / July 7, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating whether the following mergers are fair to shareholders. Halper Sadeh LLP may seek increased...

NVTA : 0.0195 (+2.63%)
MYOS : 12.1200 (-10.62%)
DCOM : 18.01 (-1.85%)
LEGAL INVESTIGATION ALERT: Halper Sadeh LLP Announces It is Investigating Whether the Following Mergers are Fair to Shareholders; Investors are Encouraged to Contact the Firm - MYOS, REXN

NEW YORK, NY / ACCESSWIRE / July 3, 2020 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating whether the following mergers are fair to shareholders. Halper Sadeh LLP may...

MYOS : 12.1200 (-10.62%)
REXN : 7.2400 (-3.21%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

MYOS RENS Technology Inc. is a BioNutrition and BioTherapeutics company which focused on the discovery, development and commercialization of products which improve muscle health and function essential to the management of sarcopenia, cachexia and degenerative muscle diseases. MYOS RENS Technology Inc.,...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 1.1167
1st Resistance Point 1.0633
Last Price 12.1200
1st Support Level 0.9833
2nd Support Level 0.9567
3rd Support Level N/A

See More

Last Price 12.1200
52-Week High 3.8500
Fibonacci 61.8% 2.6624
Fibonacci 50% 2.2956
Fibonacci 38.2% 1.9288
52-Week Low 0.7412

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar